AAAAAA
Results: 51-73/73
Authors:
Kaufmann, GR
Zaunders, JJ
Cunningham, P
Cooper, DA
Citation: Gr. Kaufmann et al., Phenotypic analysis of CD8(+) T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA, AIDS RES H, 15(11), 1999, pp. 963-972
Authors:
Ehleringer, JR
Cooper, DA
Lott, MJ
Cook, CS
Citation: Jr. Ehleringer et al., Geo-location of heroin and cocaine by stable isotope ratios, FOREN SCI I, 106(1), 1999, pp. 27-35
Authors:
Easterbrook, PJ
Goodall, RL
Babiker, AG
Yu, LM
Smith, D
Cooper, DA
Gazzard, BG
Citation: Pj. Easterbrook et al., Are HIV-infected patients with rapid CD4 cell decline a subgroup who benefit from early antiretroviral therapy?, J ANTIMICRO, 43(3), 1999, pp. 379-388
Authors:
Law, MG
de Winter, L
McDonald, A
Cooper, DA
Kaldor, JM
Citation: Mg. Law et al., AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment, AIDS, 13(2), 1999, pp. 263-269
Authors:
Dore, GJ
Correll, PK
Li, YM
Kaldor, JM
Cooper, DA
Brew, BJ
Citation: Gj. Dore et al., Changes to AIDS dementia complex in the era of highly active antiretroviral therapy, AIDS, 13(10), 1999, pp. 1249-1253
Authors:
Cooper, DA
Citation: Da. Cooper, David A Cooper - Lifeline, LANCET, 354(9184), 1999, pp. 1134-1134
Authors:
Carr, A
Samaras, K
Thorisdottir, A
Kaufmann, GR
Chisholm, DJ
Cooper, DA
Citation: A. Carr et al., Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study, LANCET, 353(9170), 1999, pp. 2093-2099
Authors:
Cooper, DA
Eldridge, AL
Peters, JC
Citation: Da. Cooper et al., Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: A review of recent research, NUTR REV, 57(7), 1999, pp. 201-214
Authors:
Cooper, DA
Eldridge, AL
Peters, JC
Citation: Da. Cooper et al., Dietary carotenoids and lung cancer: A review of recent research, NUTR REV, 57(5), 1999, pp. 133-145
Authors:
Correll, PK
Law, MG
McDonald, AM
Cooper, DA
Kaldor, JM
Citation: Pk. Correll et al., HIV disease progression in Australia in the time of combination antiretroviral therapies, MED J AUST, 170(6), 1999, pp. 285-285
Authors:
Rock, CL
Thornquist, MD
Kristal, AR
Patterson, RE
Cooper, DA
Neuhouser, ML
Neumark-Sztainer, D
Cheskin, LJ
Citation: Cl. Rock et al., Demographic, dietary and lifestyle factors differentially explain variability in serum carotenoids and fat-soluble vitamins: Baseline results from the sentinel site of the olestra post-marketing surveillance study, J NUTR, 129(4), 1999, pp. 855-864
Authors:
Dore, GJ
Cooper, DA
Barrett, C
Goh, LE
Thakrar, B
Atkins, M
Citation: Gj. Dore et al., Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR), J INFEC DIS, 180(3), 1999, pp. 607-613
Authors:
Zaunders, JJ
Cunningham, PH
Kelleher, AD
Kaufmann, GR
Jaramillo, AB
Wright, R
Smith, D
Grey, P
Vizzard, J
Carr, A
Cooper, DA
Citation: Jj. Zaunders et al., Potent antiretroviral therapy of primary human immunodeficiency virus type1 (HIV-1) infection: Partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia, J INFEC DIS, 180(2), 1999, pp. 320-329
Authors:
Wilkinson, J
Zaunders, JJ
Carr, A
Cooper, DA
Citation: J. Wilkinson et al., CD8(+) anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: Loss of CASA is associated with loss of viremia, J INFEC DIS, 180(1), 1999, pp. 68-75
Authors:
Lindback, S
Vizzard, J
Cooper, DA
Gaines, H
Citation: S. Lindback et al., Long-term prognosis following zidovudine monotherapy in primary human immunodeficiency virus type 1 infection, J INFEC DIS, 179(6), 1999, pp. 1549-1552
Authors:
Kelleher, AD
Sewell, WA
Cooper, DA
Citation: Ad. Kelleher et al., Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects, CLIN EXP IM, 115(1), 1999, pp. 147-152
Authors:
Cooper, DA
Citation: Da. Cooper, Immunological effects of antiretroviral therapy, ANTIVIR TH, 3, 1998, pp. 19-23
Authors:
Carr, A
Cooper, DA
Citation: A. Carr et Da. Cooper, HIV and AIDS - Gap between biology and reality in AIDS, LANCET, 352, 1998, pp. 16-16
Authors:
Correll, PK
Law, MG
McDonald, AM
Cooper, DA
Kaldor, JM
Citation: Pk. Correll et al., HIV disease progression in Australia in the time of combination antiretroviral therapies, MED J AUST, 169(9), 1998, pp. 469-472
Authors:
Murray, JM
Kaufmann, G
Kelleher, AD
Cooper, DA
Citation: Jm. Murray et al., A model of primary HIV-1 infection, MATH BIOSCI, 154(2), 1998, pp. 57-85
Authors:
Kaufmann, GR
Cunningham, P
Kelleher, AD
Zaunders, J
Carr, A
Vizzard, J
Law, M
Cooper, DA
Citation: Gr. Kaufmann et al., Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection, J INFEC DIS, 178(6), 1998, pp. 1812-1815
Authors:
Newell, M
Milliken, S
Goldstein, D
Lewis, C
Boyle, M
Dolan, G
Ryan, S
Cooper, DA
Citation: M. Newell et al., A phase II study of liposomal doxorubicin in the treatment of HIV-related Kaposi's sarcoma, AUST NZ J M, 28(6), 1998, pp. 777-783
Authors:
Cooper, DA
Citation: Da. Cooper, Effect of lamivudine on hepatitis B virus-human immunodeficiency virus coinfected patients from the CAESAR study, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 415-416